BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6124268)

  • 1. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker duration of action and implications for therapy.
    Kostis JB
    Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
    Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
    Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise training during chronic beta blockade in cardiovascular disease.
    Fletcher GF
    Am J Cardiol; 1985 Apr; 55(10):110D-113D. PubMed ID: 2859788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nadolol in thyrotoxicosis.
    Peden NR; Isles TE; Stevenson IH; Crooks J
    Br J Clin Pharmacol; 1982 Jun; 13(6):835-40. PubMed ID: 6124267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
    Hornung RS; Gould BA; Kieso H; Raftery EB
    Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
    Omvik P; Lund-Johansen P; Haugland H
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of atenolol and metoprolol in the treatment of hypertension.
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
    Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.